- Research Ethics
- Health Canada
-
- Food and Drugs Act
- Food and Drug Regulations
- Guidance Document: Part C, Division 5 of the Food and Drug Regulations “Drugs for Clinical Trials Involving Human Subjects” (GUI-0100)
- Guidance Document For Clinical Trial Sponsors: Clinical Trial Applications
- Clinical Trial Applications (CTAs)
- Cannabis Act
- Cannabis Regulations
- A Guide to Health Canada Inspections
- Research Involving the First Nations, Inuit and Métis Peoples of Canada
-
- The Indigenous Research Level of Engagement Tool (IRLET)
- Collaborative Indigenous Research (CIR) Digital Garden
- Memorial University's Indigenous Research Agreement Template
- Indigenous Community Research Partnerships (ICRP) Online Open Education Training
- Writing Guide for Indigenous Content | Government of BC
- San'yas Indigenous Cultural Safety Training
- In Plain Sight: Addressing Indigenous-specific Racism and Discrimination in B.C. Health Care
- Bringing Ethics Review Home to Cowichan: Indigenizing Ethics Review in British Columbia, Canada
- Indigenous Data Sovereignty: Towards an Agenda
- The First Nations Principles of OCAP
- BC SUPPORT Unit: Indigenous Knowledges for Decolonized Research and Evaluation Practices
- Internal Summary Report: BC Research Ethics Board Environmental Scan & Ethics Sharing Circles (October 2022)
- The International Council For Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH)
-
- ICH Harmonized Tripartite Guideline: General Considerations for Clinical Studies E8(R1)
- ICH Guidance Document: Good Clinical Practice: Integrated Addendum to E6(R1) ICH Topic E6(R2)
- ICH Harmonized Tripartite Guideline: Choice of Control Group and Related Issues in Clinical Trials E10
- ICH Harmonized Guideline: General Principles for Planning and Design of Multi-Regional Clinical Trials E17
- ICH Harmonized Tripartite Guideline: Quality Risk Management Q9
- World Health Organization (WHO)
- Additional Resources
